Impact of Ezetimibe on New‐Onset Diabetes: A Substudy of IMPROVE‐IT

• Nishant P. Shah,
• Darren K. McGuire,
• Christopher P. Cannon,
• Robert P. Giugliano,
• Yuliya Lokhnygina,
• Courtney B. Page,
• Andrew M. Tershakovec,
• Eugene Braunwald,
• Michael A. Blazing

Affiliations

Nishant P. Shah

Duke University School of Medicine Durham NC USA

Darren K. McGuire

University of Texas Southwestern Medical Center Dallas TX USA

Christopher P. Cannon

TIMI Study Group, Brigham and Women’s Hospital Boston MA USA

Robert P. Giugliano

TIMI Study Group, Brigham and Women’s Hospital Boston MA USA

Yuliya Lokhnygina

Duke University School of Medicine Durham NC USA

Courtney B. Page

Duke Clinical Research Institute NC Durham USA

Andrew M. Tershakovec

Merck & Co., Inc. Kenilworth NJ USA

Eugene Braunwald

TIMI Study Group, Brigham and Women’s Hospital Boston MA USA

Michael A. Blazing

Duke University School of Medicine Durham NC USA